CiPA Phase 1 ECG Biomarker Validation Study
Conditions
- Drug-induced QT Prolongation
- Pharmacokinetics
- Pharmacodynamics
Interventions
- DRUG: Ranolazine
- DRUG: Verapamil
- DRUG: Lopinavir / Ritonavir
- DRUG: Chloroquine
- DRUG: Placebo
- DRUG: Dofetilide and Diltiazem
Sponsor
Food and Drug Administration (FDA)
Collaborators